News in the Life Sciences Industry

TOKYO, March 27, 2019 /PRNewswire/ -- The Global Health Innovative Technology (GHIT) Fund announced today a total of 2.86 billion yen (US$25.8 million*) to support 10 partnerships to develop new lifesaving drugs, vaccines, and diagnostics for malaria, tuberculosis, dengue, leishmaniasis, and... Read more ››

LONDON, March 27, 2019 /PRNewswire/ -- Global Anticoagulant Reversal Drugs Market: Overview
The global anticoagulant reversal drugs market report comprises an elaborate executive summary, which includes a snapshot that provides information about various segments of the market.It... Read more ››

LONDON, March 27, 2019 /PRNewswire/ -- About this market
Neuroblastoma is the most common type of childhood cancer. and its incidence is gradually increasing across the world. The exact etiological factor contributing to neuroblastoma remains undefined. However, the rising birth... Read more ››

PLYMOUTH MEETING, Pa., March 27, 2019 /PRNewswire/ -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO) today announced that management will present at the H.C. Wainwright Global Life Sciences Conference on Monday, April 8, 2019 at 4:10 p.m. local time. The conference is being held at the Grosvenor... Read more ››

STAINES-UPON-THAMES, United Kingdom, March 27, 2019 /PRNewswire/ -- Mallinckrodt plc (NYSE: MNK), a leading global specialty pharmaceutical... Read more ››

WELLINGTON, New Zealand, March 26, 2019 /PRNewswire/ -- Volpara Solutions announced today the launch of an expanded agreement enabling the worldwide distribution of its industry-leading Read more ››

Lucy Dodd will begin rehabilitation training after national fundraising campaign with support from the Association for the Independence of Disabled People

AZ Maria Middelares will be the first private hospital in Europe to use AI for workflow prioritization

CAMBRIDGE, Mass. and LONDON, March 26, 2019 /PRNewswire/ -- TCR(2) Therapeutics Inc. (Nasdaq: TCRR), a clinical-stage immunotherapy company developing the next generation of novel T cell receptor (TCR) therapies for patients suffering from cancer, today announced it has selected the... Read more ››

LONDON, March 25, 2019 /PRNewswire/ -- About this market
With the rapid onset of modernization, the lifestyle of people is also changing. The prevalence of such health conditions is rising globally due to the sedentary lifestyle. Furthermore, the high prevalence of conditions such... Read more ››